Geeso, J.B.; Galan, C.I. Diabetic Neuropathic Pain: Pathophysiology & Treatment. International Clinical and Medical Case Reports 2023, 2, 1–8, doi:10.59657/2837-5998.brs.23.015.
Geeso, J.B.; Galan, C.I. Diabetic Neuropathic Pain: Pathophysiology & Treatment. International Clinical and Medical Case Reports 2023, 2, 1–8, doi:10.59657/2837-5998.brs.23.015.
Geeso, J.B.; Galan, C.I. Diabetic Neuropathic Pain: Pathophysiology & Treatment. International Clinical and Medical Case Reports 2023, 2, 1–8, doi:10.59657/2837-5998.brs.23.015.
Geeso, J.B.; Galan, C.I. Diabetic Neuropathic Pain: Pathophysiology & Treatment. International Clinical and Medical Case Reports 2023, 2, 1–8, doi:10.59657/2837-5998.brs.23.015.
Abstract
Diabetes mellitus is the global epidemic of the 21st century affecting millions worldwide. Usually, patients with long-standing type one diabetes (T1D) or type two diabetes (T2D) tend to develop complications. A common complication is the degenerative of the nerves in the peripheral nervous system (PNS). This complication is known as distal symmetric polyneuropathy or just diabetic neuropathy. A variety of symptoms can be experienced with this complication, including pain and numbness. One characterization of this complication is the sensory loss that begins in the lower extremities and spreads substantially to the fingers and hand. There is no clear mechanism for how this happens in diabetic patients. Studies have shown that nerve damage from this complication can be due to oxidative stress, sorbitol accumulation, and advanced glycation end products (AGEs). Some of the most common medications being provided for diabetic neuropathic pain (DNP) include amitriptyline and desipramine. Other medications also include gabapentin and duloxetine. There are noninvasive options, such as acupuncture, that could provide beneficial data if rigorous studies are conducted. A number of new studies are being completed to identify more effective treatments for this condition.
Biology and Life Sciences, Endocrinology and Metabolism
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
